I have tried repeatedly to post on RB. It never seem to get up on the board, although it says that it has been posted...very weird............Foam
1. Apparently,it may be a while before another licensing agreement is concluded......fine. I want them to make the best deal they can, and if it takes more time for blind tests, so be it.
2...." a rapid test similar to the well known pregnancy tests." That is a strange way to put it, as the Abbott architect series is not exactly going to be slow. I assume they aren't talking about an over-the-counter cancer test........LOL... I don't think the medical community is ready for that, much less the general public!
3.As has already been discussed, the PAP test ( and the corresponding test for prostate that they might come up with )is the most efficient use of RECAF for building the success of Biocurex. I am very pleased they are going to persue this using HISTO.
The future of medicine is clearly headed for a nexus of AI and Surgeon, and if RECAF can provide a tag for ai to read, the result can only be positive.
4.The stated ultimate goal of directed therapy against cancer cells in-situ with the agent being delivered by ReCAF is a huge one that would take possibly multiple years of research but it is a logical end game.
5."Financing through additional strategic equity investment is anticipated." This line from par. 8 frankly makes me a little nervous and it baffles me. What could it mean? Preferred shares? I don't know.
6.As for getting a new listing, it cannot happen soon enough. Dr. MORO, call your agent.
.
........................................Foam
